Testing Cabozantinib With or Without Atezolizumab in Patients With Advanced Papillary Kidney Cancer, PAPMET2 Trial
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Benjamin L Maughan
SWOG Cancer Research Network
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
199 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Banner Md Anderson Cancer Center
Gilbert, Arizona, United States
- Cancer Center at Saint Joseph'S
Phoenix, Arizona, United States
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Kaiser Permanente-Anaheim
Anaheim, California, United States
- Kaiser Permanente-Baldwin Park
Baldwin Park, California, United States
- Kaiser Permanente-Bellflower
Bellflower, California, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Epic Care-Dublin
Dublin, California, United States
- Epic Care Partners in Cancer Care
Emeryville, California, United States
- Kaiser Permanente-Fontana
Fontana, California, United States
- Kaiser Permanente South Bay
Harbor City, California, United States
- Kaiser Permanente-Irvine
Irvine, California, United States
- Kaiser Permanente Los Angeles Medical Center
Los Angeles, California, United States
- Kaiser Permanente West Los Angeles
Los Angeles, California, United States
- Contra Costa Regional Medical Center
Martinez, California, United States
- Kaiser Permanente-Ontario
Ontario, California, United States
- Kaiser Permanente - Panorama City
Panorama City, California, United States
- Kaiser Permanente-Riverside
Riverside, California, United States
- University of California Davis Comprehensive Cancer Center
Sacramento, California, United States
- Kaiser Permanente-San Diego Zion
San Diego, California, United States
- Kaiser Permanente-San Marcos
San Marcos, California, United States
- Epic Care Cyberknife Center
Walnut Creek, California, United States
- Kaiser Permanente-Woodland Hills
Woodland Hills, California, United States
- Medstar Georgetown University Hospital
Washington D.C., District of Columbia, United States
- Saint Alphonsus Cancer Care Center-Boise
Boise, Idaho, United States
- Saint Luke'S Cancer Institute - Boise
Boise, Idaho, United States
- Saint Alphonsus Cancer Care Center-Caldwell
Caldwell, Idaho, United States
- Kootenai Health - Coeur D'Alene
Coeur d'Alene, Idaho, United States
- Saint Luke'S Cancer Institute - Fruitland
Fruitland, Idaho, United States
- Saint Luke'S Cancer Institute - Meridian
Meridian, Idaho, United States
- Saint Alphonsus Cancer Care Center-Nampa
Nampa, Idaho, United States
- Saint Luke'S Cancer Institute - Nampa
Nampa, Idaho, United States
- Kootenai Clinic Cancer Services - Post Falls
Post Falls, Idaho, United States
- Kootenai Clinic Cancer Services - Sandpoint
Sandpoint, Idaho, United States
- Saint Luke'S Cancer Institute - Twin Falls
Twin Falls, Idaho, United States
- Illinois Cancercare-Bloomington
Bloomington, Illinois, United States
- Illinois Cancercare-Canton
Canton, Illinois, United States
- Illinois Cancercare-Carthage
Carthage, Illinois, United States
- Northwestern University
Chicago, Illinois, United States
- Carle at the Riverfront
Danville, Illinois, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 24 Mar 2023
- Primary completion
- 1 Jul 2027
- Completion
- 1 Jul 2027
- Last update posted
- 13 May 2026
- Registered enrollment
- 200
- Registry id
- NCT05411081
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.